Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-talk between next generation sequencing methodologies to identify genomic signatures of esophageal cancer.

Critical reviews in oncology/hematology - 1 Jun 2021

Verma Renu, Sattar Real Sumayya Abdul, Nimisha, Apurva, Kumar Arun, Sharma Abhay Kumar, Sumi Mamta Parveen, Ahmad Ejaj, Ali Asgar, Mahajan Bhawna, Saluja Sundeep Singh

Abstract excerpt

The asymptomatic behaviour of esophageal cancerous cells at early stages develops advanced clinical presentation of the disease, resulting in poor prognosis and curbed intervention of therapeutic modalities. The endeavours to detect diagnostic and prognostic markers have been proven futile at the clinical platform. While several biomarkers have been investigated, including CYFRA 21-1, carcinoembryonic antigen and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Esophageal Cancer Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Keratin-19

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 33961993
DOI: 10.1016/j.critrevonc.2021.103348

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-talk between next generation sequencing methodologies to identify genomic signatures of esophageal cancer.PMID 33961993Read ↗

Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.Semantic proximity Read ↗

Genome Sequencing in Esophageal Squamous Cell Carcinoma.Semantic proximity Read ↗

Genomics of Esophageal Cancer and Biomarkers for Early Detection.Semantic proximity Read ↗

Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal EvolutionSemantic proximity Read ↗

Unraveling the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma: the “omics” eraSemantic proximity Read ↗

Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.Semantic proximity Read ↗

Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.Semantic proximity Read ↗

Whole-Exome Sequencing of Esophageal Submucosal Gland Duct AdenocarcinomaSemantic proximity Read ↗

Integrative proteogenomic characterization of early esophageal cancerSemantic proximity Read ↗

Integrative proteogenomic characterization of early esophageal cancer.Semantic proximity Read ↗

The potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinoma.Semantic proximity Read ↗

Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.